RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC

Clinical trial NCT05979740 · UNKNOWN

Trial details

NCT number: NCT05979740
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Muscle Invasive Bladder Cancer HER2 Expression Radiotherapy PD-1 Antibody-drug Conjugates

Start date: 2023-08-01
Primary completion: 2023-12-13
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.